Home › Therapeutic areas › Hematology › Sickle Cell Disease

Sickle Cell Disease (3 companies)

Companies with an active program in Sickle Cell Disease.

Ticker Company Therapeutic areas Programs Lead stage Programs
BEAM Beam Therapeutics HematologyMetabolic+1 Rare 1 Phase 2 6
IRON Disc Medicine GI/HepatologyHematology+2 Rare 1 Phase 3 9
VTVT vTv Therapeutics HematologyMetabolic+1 Rare 1 Phase 3 9